Personal tools

MCL coexpression mm9:958: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001016!1.78e-32!75;UBERON:0001017!4.38e-32!73;UBERON:0000073!4.41e-26!54;UBERON:0001049!1.01e-24!52;UBERON:0005068!1.01e-24!52;UBERON:0006241!1.01e-24!52;UBERON:0007135!1.01e-24!52;UBERON:0002020!3.98e-24!34;UBERON:0002346!6.84e-24!64;UBERON:0003075!6.84e-24!64;UBERON:0007284!6.84e-24!64;UBERON:0004121!9.13e-24!95;UBERON:0000924!9.13e-24!95;UBERON:0006601!9.13e-24!95;UBERON:0003080!7.39e-22!40;UBERON:0002780!3.68e-21!39;UBERON:0001890!3.68e-21!39;UBERON:0006240!3.68e-21!39;UBERON:0000955!5.79e-21!47;UBERON:0006238!5.79e-21!47;UBERON:0002616!3.04e-20!46;UBERON:0003528!3.69e-20!29;UBERON:0002791!3.69e-20!29;UBERON:0001893!3.69e-20!29;UBERON:0003056!4.78e-19!49;UBERON:0010371!5.19e-19!73;UBERON:0010314!4.35e-14!92;UBERON:0000956!5.20e-14!21;UBERON:0001869!5.20e-14!21;UBERON:0000203!5.20e-14!21;UBERON:0002619!2.36e-11!17;UBERON:0002021!2.54e-09!10;UBERON:0000411!2.54e-09!10;UBERON:0001950!2.54e-09!10;UBERON:0002420!2.32e-07!8;UBERON:0007245!2.32e-07!8;UBERON:0010009!2.32e-07!8;UBERON:0010011!2.32e-07!8;UBERON:0000454!2.32e-07!8
|ontology_enrichment_uberon=UBERON:0001016!1.78e-32!75;UBERON:0001017!4.38e-32!73;UBERON:0000073!4.41e-26!54;UBERON:0001049!1.01e-24!52;UBERON:0005068!1.01e-24!52;UBERON:0006241!1.01e-24!52;UBERON:0007135!1.01e-24!52;UBERON:0002020!3.98e-24!34;UBERON:0002346!6.84e-24!64;UBERON:0003075!6.84e-24!64;UBERON:0007284!6.84e-24!64;UBERON:0004121!9.13e-24!95;UBERON:0000924!9.13e-24!95;UBERON:0006601!9.13e-24!95;UBERON:0003080!7.39e-22!40;UBERON:0002780!3.68e-21!39;UBERON:0001890!3.68e-21!39;UBERON:0006240!3.68e-21!39;UBERON:0000955!5.79e-21!47;UBERON:0006238!5.79e-21!47;UBERON:0002616!3.04e-20!46;UBERON:0003528!3.69e-20!29;UBERON:0002791!3.69e-20!29;UBERON:0001893!3.69e-20!29;UBERON:0003056!4.78e-19!49;UBERON:0010371!5.19e-19!73;UBERON:0010314!4.35e-14!92;UBERON:0000956!5.20e-14!21;UBERON:0001869!5.20e-14!21;UBERON:0000203!5.20e-14!21;UBERON:0002619!2.36e-11!17;UBERON:0002021!2.54e-09!10;UBERON:0000411!2.54e-09!10;UBERON:0001950!2.54e-09!10;UBERON:0002420!2.32e-07!8;UBERON:0007245!2.32e-07!8;UBERON:0010009!2.32e-07!8;UBERON:0010011!2.32e-07!8;UBERON:0000454!2.32e-07!8
|tfbs_overrepresentation_for_novel_motifs=1.01838,0.289542,0.96259,0.434198,0.260188,0.448401,0.538088,0.173246,0.535519,0.386846,0.494602,0.526159,0.992329,0.550255,0.275867,0,0.742571,0.252772,0.160384,0.29826,0.332107,0.0622758,0.549359,0.717658,0.374936,1.41403,0.909128,0.469052,0.303071,0.757024,0.455168,0.843667,0.250677,0.136998,0.276324,0.0711618,0.678971,0.522578,0.221921,0.570041,0.256422,0.460258,0.0558565,0.761266,0.0824666,0.423266,0.662995,0.484612,0.170971,0.305876,0.725127,0.604356,0.732634,0.985264,1.00271,0.557354,0.314394,0.513517,0.447041,0.555328,0.823643,0.613749,0.192045,0.713876,0.568415,0.754324,1.139,1.48833,1.9158,1.34113,0.922232,0.178433,0.872563,1.03623,0.140213,0.409836,0.136938,1.56933,0.806481,0.336166,0.179489,0.759925,0.612313,0.167672,0.920903,0.108172,0.123242,0.376919,0.667883,1.65055,1.20871,0.925879,0.856465,0.265734,0.62322,0.202284,0.982739,0.859272,0.663249,0.332938,0.242106,0.843387,0.967837,0.725721,0.724668,0.459825,0.784351,1.20804,0.340849,0.333829,1.00333,0.96962,0.895335,0.499714,1.21576,0.254749,0.333069,0.437894,0.743872,0.238599,1.04163,0.692953,0.579418,0.650748,1.26989,0.810177,0.546178,0.849691,1.13749,1.35892,0.950857,0.427043,1.10792,0.570914,1.23736,4.28091,0.401212,0.461647,1.18819,2.01886,1.6187,1.14372,0.591394,0.854131,0.718197,0.460705,0.666107,1.9792,0.403515,0.724779,0.120154,2.79776,0.986833,0.207643,0.569994,1.06851,0.605358,0.287226,0.39061,0.400939,1.1977,0.920047,0.810622,0.383936,0.714896,0.562634,0.676555,0.524587,0.0131724
}}
}}

Revision as of 19:10, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr14:77556637..77556650,+p2@Enox1
Mm9::chr1:160292549..160292559,+p9@Astn1
Mm9::chr3:118132959..118132992,+p@chr3:118132959..118132992
+
Mm9::chr3:118133217..118133286,+p@chr3:118133217..118133286
+
Mm9::chr3:118134337..118134383,+p@chr3:118134337..118134383
+
Mm9::chr3:118134411..118134437,+p@chr3:118134411..118134437
+
Mm9::chr3:118134444..118134456,+p@chr3:118134444..118134456
+
Mm9::chr6:138371615..138371665,-p3@Lmo3


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
nervous system1.78e-3275
central nervous system4.38e-3273
regional part of nervous system4.41e-2654
neural tube1.01e-2452
neural rod1.01e-2452
future spinal cord1.01e-2452
neural keel1.01e-2452
gray matter3.98e-2434
neurectoderm6.84e-2464
neural plate6.84e-2464
presumptive neural plate6.84e-2464
ectoderm-derived structure9.13e-2495
ectoderm9.13e-2495
presumptive ectoderm9.13e-2495
anterior neural tube7.39e-2240
regional part of forebrain3.68e-2139
forebrain3.68e-2139
future forebrain3.68e-2139
brain5.79e-2147
future brain5.79e-2147
regional part of brain3.04e-2046
brain grey matter3.69e-2029
regional part of telencephalon3.69e-2029
telencephalon3.69e-2029
pre-chordal neural plate4.78e-1949
ecto-epithelium5.19e-1973
structure with developmental contribution from neural crest4.35e-1492
cerebral cortex5.20e-1421
cerebral hemisphere5.20e-1421
pallium5.20e-1421
regional part of cerebral cortex2.36e-1117
occipital lobe2.54e-0910
visual cortex2.54e-0910
neocortex2.54e-0910
basal ganglion2.32e-078
nuclear complex of neuraxis2.32e-078
aggregate regional part of brain2.32e-078
collection of basal ganglia2.32e-078
cerebral subcortex2.32e-078


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}